20150708 Northland Securities 降低目标价, 评级:超出大盘, 目标价:$31.00 -> $28.00
20150707 Needham & Company LLC 纳入研究范围, 评级:买入, 目标价:$30.00
更多分析和资讯,请关注微-信-公-众-号 stock_tong查看全文
$K2M Group(KTWO)$ 内部交易: 2015-07-17,Director,FERRER CARLOS A ,卖出,86407普通股, $22.37
$K2M Group(KTWO)$ 内部交易: 2015-07-17,10% Owner,WCAS MANAGEMENT CORP ,卖出,383普通股, $22.60
$K2M Group(KTWO)$ 内部交易: 2015-07-17,10% Owner,Welsh, Carson, Anderson & Stow ,卖出,467293普通股, $22.60
$K2M Group(KTWO)$ 内部交易: 2015-07-17,10% Owner,WCAS Capital Partners IV, L.P. ,卖出,6842普通股, $22.60
$K2M Group(KTWO)$ 内部交易: 2015-07-13,10% Owner,WCAS Capital Partners IV, L.P. ,卖出,45616普通股, $22.60
$K2M Group(KTWO)$ 内部交易: 2015-07-13,10% Owner,Welsh, Carson, Anderson & Stow ,卖出,3115287普通股, $22.60
$K2M Group(KTWO)$ 内部交易: 2015-07-13,10% Owner,WCAS MANAGEMENT CORP ,卖出,2551普通股, $22.60
$K2M Group(KTWO)$ 内部交易: 2015-06-24,Chief Medical Officer,KOSTUIK JOHN PHILIP MD ,卖出,6459普通股, $24.27
$K2M Group(KTWO)$ 内部交易: 2015-06-22,Chief Medical Officer,KOSTUIK JOHN PHILIP MD ,卖出,7210普通股, $25.36
$K2M Group(KTWO)$ 内部交易: 2015-06-23,Chief Medical Officer,KOSTUIK JOHN PHILIP MD ,卖出,10668普通股, $24.89